Aristotle University Of Thessaloniki (AUTH)
Σύνδρομο αποφρακτικών απνοιών-υποπνοιών ύπνου, φλεγμονή και οξειδωτικό στρες σε χρονίως αιμοκαθαιρόμενους ασθενείς
Abstract
dc:descriptionSleep apnea syndrome (SAS) is a sleep disorder very common among hemodialysis patients. In the general population the syndrome is related to cardiovascular risk augmentation through inflammation and oxidative stress. The aim of the present study was to investigate the role of SAS in the promotion of inflammation and oxidative stress in hemodialysis patients.Thirty-seven hemodialysis patients (23 males) participated in the study. All the participants went through an overnight polysomnography with a “SOMNOscreenTM” device (SOMNOmedics & co GmbH, Germany) and their sleep parameters were recorded (AHI-Apnea/Hypopnea Index, RDI-Respiratory Disturbance Index, DI-Desaturation Index, mean and minimum SpO2, percentage of sleep time with SpO2<90% and total sleep time). The following morning blood samples were obtained and serum levels of ICAM-1, VCAM-1, L-selectin, TNF-α, IL-6, MPO, oxLDL and hs-CRP were measured.The patients’ mean age was 57.8±12.4 years, their mean BMI 26.8±5.6 kg/m2 and their median duration of hemodialysis 21.5 months (range: 3.1 to 218). ICAM-1 and VCAM-1 correlated with duration of hemodialysis (r=0.421, p=0.009 and r=0.525, p=0.001, respectively) and L-selectin with RDI (r=0.363, p=0.027). TNF-α correlated with BMI (r=0.510, p<0.0001) and total sleep time (r=0.370, p=0.027), while IL-6 with age (r=0.363, p= 0.027), AHI (r=0.385, p=0.018), DI (r=0.336, p=0.042), percentage of sleep time with SpO2<90% (r=0.415, p=0.012) and mean SpO2 (r=-0.364, p=0.027). MPO correlated with AHI (r=0.385, p=0.018), DI (r=0.380, p=0.02) and percentage of sleep time with SpO2<90% (r=0.388, p=0.019) and oxLDL with BMI (r=0.443, p=0.007), AHI (r=0.395, p=0.015), RDI (r=0.328, p=0.048) and the total sleep time with SpO2<90% (r=0.389, p=0.019). Finally, hs-CRP showed no significant correlation. Based on the polysomnography study, 11 patients had mild SAS, 12 patients moderate and 14 patients severe. Age, sex, BMI and duration of hemodialysis showed no statistically significant differences among the three groups of SAS severity. Α statistically significant difference of MPO was found among the three groups of SAS severity. Comparison of each pair of groups showed that MPO was significantly lower among ESRD patients with mild and moderate SAS, compared to the ones with severe SAS (p=0.018 and p=0.011, respectively). A statistically significant difference of oxLDL levels (p<0.0001) was found among the three groups of SAS severity, as well. Hemodialysis patients with mild SAS had statistically significant lower oxLDL levels than the ones with moderate (p<0.0001) and severe SAS (p<0.0001). The findings of the present study indicate that, in hemodialysis patients, SAS promotes the adhesion of monocytes to the vascular endothelial cells, the production of cytokines related to inflammation and of oxidative stress and the oxidation of LDL. Thus, this study enforces the theory that SAS in hemodialysis patients promotes inflammation and oxidative stress and is related to the augmented cardiovascular risk.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Nikitidou, Olga
- Νικητίδου, Όλγα
Subjects
dc:subject × 20- Χρόνια αιμοκάθαρση
- Χρόνια νεφρική νόσος
- Αιμοκάθαρση
- Σύνδρομο αποφρακτικών απνοιών-υποπνοιών ύπνου
- Φλεγμονές
- Οξειδωτικό στρες
- Μόρια προσκόλλησης του ενδοθηλίου
- Καρδιαγγειακή νόσος
- Chronic hemodialysis
- Chronic kidney disease
- Hemodialysis
- Sleep apnea syndrome
- Inflammation
- Oxidative stress
- Adhesion molecules
- Cardiovascular disease
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/34570